India’s Sun Pharma has had a host of problems at some of its own manufacturing facilities in India but it just narrowly escaped another warning letter for a…

Dublin-based Mallinckrodt company has decided it needs a U.S. campus to consolidate workers picked up in an M&A spree, as well as some more manufacturing,…

Sagent Pharmaceuticals ($SGNT) is widening its recall of antibiotics manufactured by one of its India-based contractors after a customer complained that small…

Sun Pharma continues to slog away at its remediation efforts at both its key plant in Halol as well at the four plants it got in its $4 billion buyout of…

Portola has gotten an FDA CRL largely focused on manufacturing issues for AndexXa, its breakthrough anticoagulant reversal agent. It joins a number of other…

Pfizer has decided that it does not need the legacy distribution sites that it got with the $15 billion buyout of Hospira last year and so will close four…

Life sciences company Agilent Technologies recently will invest $120 million on anew plant in Colorado to make nucleic acid APIs.

Germany’s Fresenius Kabi will have more sterile injectable production capacity as it invests $250 million to turn a U.S. site into a showcase for its sterile…